Published in Israel21c
One of the affiliated startups is Gals Bio, headed by serial femtech entrepreneur Hilla Shaviv. The company is chaired by Sandrine Montsma, formerly CEO of Contipi, sold to Kimberly Clark for $90 million.
Gals Bio has developed Tulipon, an advanced hybrid between a tampon and a menstrual cup. The disposable, biodegradable device will carry technology to monitor biomarkers in menstrual blood for anything from vitamin deficiency to cancer.